Induction Therapy of PTX+BV Followed by Atezolizumab+Nab-PTX for PD-L1+ TNBC

Clinical trial NCT06793553 · RECRUITING

Trial details

NCT number: NCT06793553
Sponsor: Japan Breast Cancer Research Group
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2024-09-13
Primary completion: 2026-03-31
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.